HS

Hans-Peter Schwarz

BS Baxter Healthcare Sa: 34 patents #11 of 1,132Top 1%
BI Baxter International: 34 patents #19 of 2,334Top 1%
BI Baxalta Incorporated: 29 patents #1 of 230Top 1%
IA Immuno Aktiengesellschaft: 27 patents #3 of 75Top 4%
BA Baxter Aktiengesellschaft: 18 patents #3 of 86Top 4%
TL Takeda Pharmaceutical Company Limited: 6 patents #248 of 1,531Top 20%
BG Baxter Innovations Gmbh: 4 patents #4 of 22Top 20%
SB Stichting Sanquin Bloedvoorziening: 3 patents #6 of 43Top 15%
📍 Wien, AT: #3 of 3,624 inventorsTop 1%
Overall (All Time): #9,130 of 4,157,543Top 1%
125
Patents All Time

Issued Patents All Time

Showing 51–75 of 125 patents

Patent #TitleCo-InventorsDate
8795658 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH Harald Arno Butterweck, Bernhard Kölbl, Lucia Hofbauer, Wolfgang Teschner 2014-08-05
8796430 Method to produce an immunoglobulin preparation with improved yield Leopold Bruckschwaiger, Sonja Svatos, Julia Nürnberger, Wolfgang Teschner, Harald Arno Butterweck +4 more 2014-08-05
8785139 Modification-dependent activity assays Alfred Weber, Andrea Engelmaier 2014-07-22
8772462 Removal of serine proteases by treatment with finely divided silicon dioxide Wolfgang Teschner, Ruth Madlener, Sonja Svatos, Azra Pljevljakovic, Alfred Weber 2014-07-08
8772240 Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidases Peter Matthiessen, Alfred Weber, Peter Turecek 2014-07-08
8735086 Kit for measuring the thrombin generation in a sample of a patient's blood or plasma Katalin Varadi, Peter Turecek, Brigitte Keil, Sylvia Peyrer-Heimstaett 2014-05-27
8703426 Composition exhibiting a von Willebrand Factor (vWF) protease activity with the amino acid sequence AAGGILHLELLV Bernhard Laemmle, Helena Elisabeth Schaller-Gerritsen, Miha Furlan, Peter Turecek, Friedrich Scheiflinger +4 more 2014-04-22
8703429 Composition exhibiting a von Willebrand Factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV Bernhard Laemmle, Helena Elisabeth Schaller-Gerritsen, Miha Furlan, Peter Turecek, Friedrich Scheiflinger +4 more 2014-04-22
8652793 Solid phase-bound elastase-binding assay for the measurement of alpha1-antitrypsin activity Alfred Weber, Andrea Engelmaier 2014-02-18
8623612 Method for testing treatment of ADAMTS13 deficiency Katalin Varadi, Hanspeter Rottensteiner, Peter Turecek, Jutta Schreiner 2014-01-07
8623352 Stabilized liquid and lyophilized ADAMTS13 formulations Peter Matthiessen, Peter Turecek 2014-01-07
8603830 Method for the determination of polysorbate 80 Alfred Weber, Andrea Engelmaier, Heinz Anderle 2013-12-10
8546332 Factor VIII polypeptide having factor VIII:C activity Petrus Lenting, Jan Aart Van Mourik, Koenraad Mertens, Hans Pannekoek, Peter Turecek +1 more 2013-10-01
8546548 Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use Wolfgang Teschner, Harald Arno Butterweck, Azra Pljevljakovic, Theresa Friederike Bauer, Bernhard Koelbl +3 more 2013-10-01
8415114 Methods of measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor and uses thereof Katalin Varadi, Hanspeter Rottensteiner, Peter Turecek, Jutta Schreiner 2013-04-09
8377375 Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors Heinz Anderle, Peter Matthiessen, Peter Turecek, Thomas Kreil, Daniel R. Boggs 2013-02-19
8343748 Preparative purification process for human furin Peter Matthiessen, Stefan Romeder-Finger, Peter Turecek 2013-01-01
8304524 Manufacture of factor H (FH) and FH-derivatives from plasma Shawn F. Bairstow, Richard J. Johnson, Sindhu Ramachandran, Ruth Madlener, Wolfgang Teschner 2012-11-06
8216793 Detection of antibody that binds to water soluble polymer-modified polypeptides Christian Lubich, Juergen Siekmann, Birgit Maria Reipert, Hartmut Ehrlich 2012-07-10
8173597 Modified recombinant factor VIII and von Willebrand factor and methods of use Peter Turecek 2012-05-08
8114633 Methods for differentiating plasma-derived protein from recombinant protein in a sample Alfred Weber, Peter Turecek 2012-02-14
7993580 Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors Heinz Anderle, Peter Matthiessen, Peter Turecek, Thomas Kreil, Daniel R. Boggs 2011-08-09
7968293 IVIG modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease Birgit Maria Reipert, Hartmut Ehrlich, Irina Elovaara 2011-06-28
7910094 Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV Bernhard Laemmle, Helena Elisabeth Schaller-Gerritsen, Miha Furlan, Peter Turecek, Friedrich Scheiflinger +4 more 2011-03-22
7807435 Method for the purification of alpha-1 proteinase inhibitor (a1PI) Peter Matthiessen, Gerald Brachtl, Peter Turecek 2010-10-05